Ovid Therapeutics Inc. (OVID)
NASDAQ · Healthcare
Ovid Therapeutics Inc. Net Income 2020–2025
Ovid Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Ovid Therapeutics Inc. net income for the quarter ending March 31, 2026 was -17.0 M, a 65.98% increase year-over-year.
- Ovid Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -44.1 M, a 54.98% increase year-over-year.
- Ovid Therapeutics Inc. annual net income for 2025 was -17.4 M, a 34.12% decrease from 2024.
- Ovid Therapeutics Inc. annual net income for 2024 was -26.4 M, a 49.50% decrease from 2023.
- Ovid Therapeutics Inc. annual net income for 2023 was -52.3 M, a 3.38% decrease from 2022.
- Ovid Therapeutics Inc. annual net income for 2022 was -54.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ovid Therapeutics Inc. Net Income — FAQ
Ovid Therapeutics Inc. (OVID) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Ovid Therapeutics Inc.'s net income?
Ovid Therapeutics Inc. (OVID) reported net income of -$17M for fiscal 2025.
Where can I see OVID's net income history?
The chart and table above show Ovid Therapeutics Inc.'s net income by year and by quarter, including the growth rate.